valuation thoughts, page-195

Following a drug into development in area where there is no effective standard of care should probably give even you a hint of what potential market penetration could be rolling.

And it is breaking down boundaries to investigate carT against a solid tumour cancer.

And it has applications into other indications

And its not the only drug in the pipeline.

There is lots to like here. There is still development to be done. But I am liking what I have seen so far.

Just as you dont like anyone making any positive posts here, I really dont get where you are coming from. You seem to be completely risk adverse. So I wonder why you would be even looking at this end of the market.

Anyway, each to their own.

It will be an interesting week ahead. DOW closed over 800 points higher on Friday. Dow futured are almost 900 points higher now. Gold price had retreated in after hour trade. Fear has been replacrd with good old fashioned greed. Buyers being tempted by cheaper prices.

The markets always present opportunity.